Overview

Pilot Study of DRibble Vaccine for Prostate Cancer Patients

Status:
Completed
Trial end date:
2018-08-15
Target enrollment:
Participant gender:
Summary
This is a pilot study of the DRibble vaccine in patients with advanced prostate cancer.
Phase:
Phase 1
Details
Lead Sponsor:
UbiVac
Collaborators:
Providence Cancer Center
Providence Cancer Center, Earle A. Chiles Research Institute
Providence Health & Services
Treatments:
Cyclophosphamide
Imiquimod
Vaccines